Crane Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crane Co. on October 26, 2009. The filing primarily addresses the announcement of results of operations for the quarter ended September 30, 2009, and provides detailed updates regarding asbestos liability claims and costs. The company is incorporated in Delaware and maintains its principal executive offices in Stamford, CT.
Key Financial Metrics: Asbestos Liability and Costs
The filing focuses on asbestos-related financial data rather than general operating revenue or profit metrics, which are referenced in attached exhibits not included in the text.
- Total Asbestos Liability: $851 million as of September 30, 2009 (down from $1,055 million recorded in 2007).
- Current Portion of Liability: $91 million, representing estimated costs to be paid within the next twelve months.
- Future Claims Projection: Approximately 68% of the total liability is attributable to future claims projected through 2017.
- Insurance Receivable Asset: $257 million as of September 30, 2009, representing probable insurance reimbursements.
- Costs Incurred (Nine Months Ended Sept 30, 2009): $86.1 million total (Settlement/Indemnity: $47.0 million; Defense: $39.1 million).
- Cash Payments (Nine Months Ended Sept 30, 2009): $34.8 million net of insurance receipts.
- Pending Claims: 70,282 claims as of September 30, 2009 (excluding 36,447 inactive maritime actions).
Material Changes Versus Prior Period
Comparing the nine-month periods ended September 30, 2009, and 2008:
- Total Costs Incurred: Increased from $71.1 million in 2008 to $86.1 million in 2009.
- Settlement Costs Incurred: Increased from $33.0 million in 2008 to $47.0 million in 2009.
- Defense Costs Incurred: Increased slightly from $38.1 million in 2008 to $39.1 million in 2009.
- Net Cash Payments: Remained relatively stable at $34.8 million in 2009 versus $34.9 million in 2008. The 2009 figure includes a $14.5 million buyout payment from Highlands Insurance Company received in January 2009.
- Claim Activity: New claims filed in the nine months ended Sept 30, 2009, were 2,900, compared to 3,585 in the same period in 2008. Dismissals increased to 6,670 in 2009 from 7,440 in 2008.
Outlook, Risks, and Management Commentary
Liability Estimate Stability: Management determined that no change to the asbestos liability estimate was warranted for the period ended September 30, 2009. The estimate covers claims filed through 2017. The company does not believe costs beyond 2017 can be reasonably estimated.
Insurance Coverage: The company has entered into "coverage-in-place" agreements with ten excess insurer groups and policy buyout agreements totaling $61.3 million. The estimated insurance recovery rate remains at approximately 33% of the liability.
Legal Developments:
- Adverse Verdicts: The company received adverse verdicts in the James Baccus ($14.35 million total) and Chief Brewer ($0.68 million) cases, both of which are under appeal.
- Favorable Rulings: A motion for judgment notwithstanding the verdict was granted in the Dennis Woodard case, though plaintiffs have appealed.
- Payments: Two judgments were paid in 2008 and 2009 (Joseph Norris and Earl Haupt) totaling approximately $2.56 million.
Risks and Uncertainties: The company highlights significant uncertainties regarding the timing, severity, and quantity of future claims. Factors such as new mesothelioma claims, average settlement costs, dismissal rates, and defense costs could materially alter the liability estimate. Additionally, the financial viability of insurers and the interpretation of policy terms affect the estimated insurance recoveries.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter ended September 30, 2009, in the attached Earnings Press Release (Exhibit 99.1) and Financial Data Supplement (Exhibit 99.2), as these are not detailed in the 8-K text.
- Monitor the status of the pending appeals in the James Baccus and Chief Brewer cases, as adverse outcomes could increase the liability estimate.
- Track the progress of negotiations with remaining excess insurers to confirm the 33% estimated recovery rate remains valid.
- Review the quarterly trend of new mesothelioma claims versus dismissals to assess the stability of the liability forecast through 2017.
- Confirm the timing of future cash outflows, noting that the $91 million current liability represents the best estimate for the next 12 months.